Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: JAMA Oncol. 2017 Aug 1;3(8):1043–1050. doi: 10.1001/jamaoncol.2016.6749

Table 2.

Levels of Agreement Between Symptomatic Toxic Effect Grades as Reported by Patients vs Clinicians

Symptomatic Toxic Effect Weighted κ (95% CI)a
Anorexia 0.22 (0.07 to 0.37)
Constipation 0.39 (0.24 to 0.54)
Cough 0.36 (0.16 to 0.56)
Diarrhea 0.63 (0.49 to 0.76)
Dyspnea 0.32 (0.13 to 0.50)
Fatigue 0.33 (0.17 to 0.49)
Hand or foot rash 0.03 (−0.05 to 0.11)
Mouth sores 0.44 (0.25 to 0.63)
Nausea 0.65 (0.49 to 0.81)
Neuropathy 0.48 (0.33 to 0.64)
Pain 0.61 (0.48 to 0.74)
Vomiting 0.82 (0.62 to 1.00)
Watery eyes 0.23 (0.00 to 0.45)
a

Weighted κ values ranging from 0.01 to 0.20 demarcate slight agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; and 0.61 or higher, substantial agreement.